Multiple myeloma has become a very treatable disease for many patients due in large part to biopharmaceutical discovery and innovation. However, a model recently developed by ICER, using a flawed value framework, threatens to put the brakes on continued progress. Read more here. (Source: Holly Campbell, PhRMA, 5/26/16)
You are here: / Will ICER Framework Destroy Progress Against Multiple Myeloma?